| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP &Chief Scientific Officer
1 company
Doberstein Stephen K is a SVP &Chief Scientific Officer at NEKTAR THERAPEUTICS. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $7.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 1,701 | $19.32 | $32,863.32 | -5.2% | |
| May 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 1,701 | $19.55 | $33,254.55 | -4.9% | |
| Apr 5, 2017 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sale+OE | 100,000 | $21.70 | $2,170,000.00 | -74.3% | |
| Feb 16, 2017 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 1,261 | $13.14 | $16,569.54 | -3.5% | |
| Nov 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 670 | $13.96 | $9,353.20 | -3.5% | |
| Aug 16, 2016 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sell | 1,336 | $17.56 | $23,460.16 | -6.6% | |
| May 17, 2016 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sale+OE | 339 | $13.58 | $4,603.62 | -24.9% | |
| Feb 17, 2016 | NKTR Nektar Therapeutics | SVP &Chief Scientific Officer | Sale+OE | 390 | $11.92 | $4,648.80 | -44.6% |